Synartro AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2011, the company has 3 employees and reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med Hurst, Magnus Oliver Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall utveckla och kommersialisera läkemedel och bedriva därmed förenlig verksamhet.
In its most recent annual report (2024), Synartro AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 5.6m.
At the end of 2024, equity financed 94.4% of the balance sheet, and current assets covered short-term debt 4.3 times.
Frequently asked questions
What is the Org number of Synartro AB?
Synartro AB is registered with Bolagsverket / SCB under Org 5568664220.
How many employees does Synartro AB have?
Synartro AB employs 3 people as of the latest annual report.
Who is the CEO of Synartro AB?
Magnus Oliver Hurst is the CEO of Synartro AB, in role since 2024.
Who is the chairman of Synartro AB?
Per Fredrik Lehmann chairs the board of Synartro AB, in role since 2020.
Where is Synartro AB headquartered?
Synartro AB's registered address is Dalgatan 16 A.
